MYO logo

MYOMO INC

MYONYSE AMERICAN
🏆 #4362 by market capUS Equity
$131.88▲ $3.94 (+2.99%)
Simulated price
🔔
Track MYO
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 3.0%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$60M
Small Cap
📈Revenue Growth (YoY)
+25.7%
High Growth
📊Gross Margin
68.3%
High
💵FCF Margin
-20.4%
Thin
⚖️P/S Ratio
1.4x
Cheap
Otter Score
72
Fair
No chart data available for MYO.

Trading Snapshot

Day Range
$130.25 – $133.48
52-Week Range
$0.61 – $1.89
Volume
$4.20B
Avg Volume
$4.46B
Shares Outstanding
38.6M
Next Earnings
Oct 25, 2026

Fundamentals Snapshot

Annual Revenue
$41M
Last Q Revenue
$12M
P/E Ratio
-4.6
P/S Ratio
1.4x
EPS (TTM)
$-0.34
Dividend Yield
0.00%
Dilution (1yr)
+7.6%

Why Investors Own MYO

  • ✓High-growth profile — revenue up +55.0% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 27% gross margin and 6% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

MYO logo

MYOMO INC

MYO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$41M▲ +25.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
65.7%▼ −7.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$14M▲ +132.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$16M▲ +249.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
41.9M▲ +7.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$5M▼ −$22M YoY
StockOtter · stockotter.space

About MYOMO INC

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
72/100

Analyst Price Target

ⓘ
Average Target
$163.16
▲ +23.7% Upside
High Target$200.34
Low Target$149.59
Based on 36 analysts

Latest News & Updates

🚀
MarketWatch·2h ago

MYOMO INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
CNBC·5h ago

Analysts lift MYO price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
CNBC·1d ago

MYOMO INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.